Holdings of HARTFORD HEALTHCARE HLS FUND
HARTFORD SERIES FUND INC · 83 declared positions · as of Mar 31, 2026
Original filing · Net assets 104.5M $ · Ten largest lines: 46.9 % of the equity sleeve
Country breakdown
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 70 | 95.2M $ | 91.68 % |
| NL | 3 | 2M $ | 1.89 % |
| GB | 2 | 1.8M $ | 1.78 % |
| CH | 2 | 1.2M $ | 1.15 % |
| BE | 1 | 1.1M $ | 1.06 % |
| DK | 1 | 791.4K $ | 0.76 % |
| HK | 2 | 770.3K $ | 0.74 % |
| IE | 1 | 532.6K $ | 0.51 % |
| CA | 1 | 443.3K $ | 0.43 % |
Sector breakdown is published in no regulatory filing: neither Form N-PORT nor the LEI reference data carries an activity code. It is absent rather than estimated.
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Eli Lilly & Co | 13,727 | 12.6M $ | 12.09 % |
| Merck & Co Inc | 58,295 | 7M $ | 6.71 % |
| Johnson & Johnson | 25,836 | 6.3M $ | 6.05 % |
| UnitedHealth Group Inc | 15,880 | 4.3M $ | 4.11 % |
| Intuitive Surgical Inc | 8,008 | 3.7M $ | 3.53 % |
| AbbVie Inc | 15,306 | 3.3M $ | 3.19 % |
| Abbott Laboratories | 29,323 | 3M $ | 2.88 % |
| Danaher Corp | 15,625 | 3M $ | 2.84 % |
| Edwards Lifesciences Corp | 35,612 | 2.9M $ | 2.73 % |
| Vertex Pharmaceuticals Inc | 5,853 | 2.6M $ | 2.50 % |
| Boston Scientific Corp | 36,858 | 2.3M $ | 2.21 % |
| CVS Health Corp | 30,494 | 2.2M $ | 2.10 % |
| Cencora Inc | 6,558 | 2.1M $ | 1.97 % |
| Regeneron Pharmaceuticals, Inc. | 2,529 | 2M $ | 1.87 % |
| HCA Healthcare Inc | 4,101 | 1.9M $ | 1.86 % |
| Thermo Fisher Scientific Inc | 3,624 | 1.8M $ | 1.71 % |
| Elevance Health Inc | 5,698 | 1.7M $ | 1.60 % |
| Medtronic PLC | 17,484 | 1.5M $ | 1.45 % |
| Cardinal Health, Inc. | 6,868 | 1.5M $ | 1.39 % |
| GSK PLC | 51,586 | 1.4M $ | 1.36 % |
| Agilent Technologies Inc | 11,491 | 1.3M $ | 1.25 % |
| United Therapeutics Corp | 2,174 | 1.3M $ | 1.23 % |
| Stryker Corp | 3,578 | 1.2M $ | 1.13 % |
| Argenx SE | 1,529 | 1.1M $ | 1.07 % |
| UCB SA | 3,637 | 1.1M $ | 1.05 % |
| Dexcom Inc | 16,874 | 1.1M $ | 1.01 % |
| Biogen Inc | 5,481 | 1M $ | 0.96 % |
| Apellis Pharmaceuticals Inc | 23,638 | 951K $ | 0.91 % |
| STERIS PLC | 4,043 | 894K $ | 0.86 % |
| Ionis Pharmaceuticals Inc | 11,237 | 843.8K $ | 0.81 % |
| Incyte Corp | 8,743 | 822.9K $ | 0.79 % |
| Alnylam Pharmaceuticals Inc | 2,464 | 815.3K $ | 0.78 % |
| Madrigal Pharmaceuticals Inc | 1,536 | 804K $ | 0.77 % |
| Ascendis Pharma A/S | 3,460 | 791.4K $ | 0.76 % |
| Bristol-Myers Squibb Co | 12,812 | 777K $ | 0.74 % |
| Elanco Animal Health Inc | 31,004 | 741.9K $ | 0.71 % |
| Galderma Group AG | 3,695 | 726.2K $ | 0.70 % |
| Cytokinetics Inc | 10,815 | 712.8K $ | 0.68 % |
| Encompass Health Corp | 6,943 | 671.6K $ | 0.64 % |
| Protagonist Therapeutics Inc | 6,317 | 665.8K $ | 0.64 % |
| Revolution Medicines Inc | 6,612 | 643K $ | 0.62 % |
| Bio-Techne Corp | 12,008 | 627.5K $ | 0.60 % |
| Disc Medicine Inc | 9,537 | 609.8K $ | 0.58 % |
| Alignment Healthcare Inc | 34,524 | 608.3K $ | 0.58 % |
| Pharvaris NV | 21,196 | 598.8K $ | 0.57 % |
| HeartFlow Inc | 24,312 | 591.5K $ | 0.57 % |
| Option Care Health Inc | 20,393 | 549K $ | 0.53 % |
| Scholar Rock Holding Corp | 10,864 | 534.1K $ | 0.51 % |
| ICON PLC | 4,813 | 532.6K $ | 0.51 % |
| Apogee Therapeutics Inc | 6,243 | 525.5K $ | 0.50 % |
| Avantor Inc | 66,012 | 517.5K $ | 0.50 % |
| Dianthus Therapeutics Inc | 6,126 | 514.1K $ | 0.49 % |
| Kymera Therapeutics Inc | 6,039 | 503K $ | 0.48 % |
| PTC Therapeutics Inc | 7,369 | 502K $ | 0.48 % |
| Mirum Pharmaceuticals Inc | 5,399 | 498.8K $ | 0.48 % |
| Structure Therapeutics Inc | 10,133 | 488.4K $ | 0.47 % |
| Arcus Biosciences Inc | 22,493 | 485.8K $ | 0.47 % |
| Natera Inc | 2,394 | 478.8K $ | 0.46 % |
| Viridian Therapeutics Inc | 24,390 | 477.1K $ | 0.46 % |
| QIAGEN NV | 11,870 | 475.3K $ | 0.46 % |
| Oculis Holding AG | 17,442 | 463.8K $ | 0.44 % |
| Xenon Pharmaceuticals Inc | 7,624 | 443.3K $ | 0.42 % |
| Acadia Healthcare Co Inc | 18,573 | 434.4K $ | 0.42 % |
| Adaptive Biotechnologies Corp | 30,861 | 428.4K $ | 0.41 % |
| AstraZeneca PLC | 2,167 | 427.4K $ | 0.41 % |
| Nuvalent Inc | 4,103 | 420.4K $ | 0.40 % |
| Celldex Therapeutics Inc | 12,569 | 398.7K $ | 0.38 % |
| Vaxcyte Inc | 6,840 | 397.5K $ | 0.38 % |
| Mineralys Therapeutics Inc | 14,421 | 390.7K $ | 0.37 % |
| Soleno Therapeutics Inc | 11,658 | 390.3K $ | 0.37 % |
| GenFleet Therapeutics Shanghai Inc | 91,400 | 389.6K $ | 0.37 % |
| Inspire Medical Systems Inc | 7,432 | 383.3K $ | 0.37 % |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 45,725 | 380.7K $ | 0.36 % |
| Immunocore Holdings PLC | 12,125 | 365.6K $ | 0.35 % |
| Immunome Inc | 16,589 | 362.8K $ | 0.35 % |
| Stoke Therapeutics Inc | 10,840 | 353K $ | 0.34 % |
| Trevi Therapeutics Inc | 28,925 | 345.1K $ | 0.33 % |
| Crinetics Pharmaceuticals Inc | 8,142 | 295.7K $ | 0.28 % |
| Aktis Oncology Inc | 14,533 | 260K $ | 0.25 % |
| Newamsterdam Pharma Co NV | 7,683 | 245.9K $ | 0.24 % |
| CG oncology Inc | 1,875 | 126.9K $ | 0.12 % |
| Corvus Pharmaceuticals Inc | 4,000 | 58.5K $ | 0.06 % |
| Eikon Therapeutics Inc | 2,100 | 22.2K $ | 0.02 % |